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Abstract
The goal of our laboratory is to study the mechanisms that promote nicotine use, particularly in
vulnerable populations such as adolescents and females. Thus, the purpose of this thesis was to
characterize age and sex differences in the motivational/rewarding effects of nicotine (Aim 1) and
withdrawal behavior (Aim 2). To more closely model human use patterns, the present study
employed nicotine vapor methods involving passive exposure for 14 days in adolescent and adult
female and male rats. Age and sex differences in approach behavior (nosepokes) were assessed in
a port that delivered nicotine plumes on Day 1 and 14. Controls received ambient air. After the
final session, rats received a nicotinic receptor antagonist to precipitate withdrawal. Then, physical
signs, anxiety-like behavior, and plasma levels of cotinine (a nicotine metabolite) were assessed.
Over time, females displayed a larger increase in approach behavior to the nicotine port than males,
an effect that was larger in adolescents. Adolescents displayed more total physical signs of
withdrawal and grooming behavior than adults, an effect that is likely related to high levels of
nosepoke responses in adolescent rats. The analysis of individual signs revealed that there were no
age or sex differences in the withdrawal-induced increases in teeth chatters. However, the
withdrawal-induced increase in blinking behavior was higher in adult versus adolescent rats,
regardless of sex. There were no group differences in anxiety-like behavior. Despite the lack of
overall group differences, a correlational analysis in adolescent females revealed that nosepoke
responses were positively correlated with the magnitude of anxiety-like behavior, but not physical
signs of withdrawal. Adolescents gained more weight than adults regardless of treatment, and the
weight gain was larger in male adolescents. Female adolescents also displayed the highest levels
of cotinine than all other groups. These findings suggest that nicotine vapor produces greater
motivational effects in adolescent females as compared to their adult and male counterparts.
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Chapter 1: Introduction
1.1 Tobacco use as a public health issue
According to the Centers for Disease Control (CDC) and the World Health Organization
(WHO), tobacco use remains the leading cause of preventable death and disease in the United
States. With approximately 1 billion smokers worldwide, more than 7 million deaths are caused
by tobacco use each year (WHO, 2017). By 2030, it is predicted that if the pattern of smoking does
not change, more than 8 million people a year will die from diseases related to tobacco use (WHO,
2011). Unfortunately, the rate at which a tobacco smoker develops a disease is quite high. More
than 16 million people in the United States are living with a disease caused by smoking, including
heart disease, cardiovascular disease, and lung cancer (Department of Health and Human Services,
2014). Also, it was estimated that the annual cost of cigarette smoking in the United States
exceeded $225 billion dollars a year in direct medical care for adults (Xu et al., 2015). Although
there are 4,800 chemicals in tobacco products, nicotine is the main psychoactive reinforcing
compound that motivates smoking behavior (Balfour, 2004). Despite the collection of negative
health consequences associated with smoking, a greater understanding is warranted to examine
how other factors may contribute to tobacco use that remain problematic. Thus, there is a strong
dire need to examine the underlying mechanisms that promote tobacco use in vulnerable
populations.
1.2 Nicotine produces rewarding effects and withdrawal symptoms following chronic
exposure
Much work has established that tobacco use is largely motivated by the presence of
nicotine, which produces dependence in humans and rodent models (Balfour, 2004; Pogocki et
al., 2007; Pontieri et al., 1996; U.S. Department of Health and Human Services, 2014). Current
theories suggest that tobacco use is motivated by both the positive and negative reinforcement
1

effects of nicotine (George and Koob, 2017). When nicotine is consumed, it produces acute
pleasurable/euphoric effects as well as relaxation, enhanced attentional processes, and motor
activation (Benowitz, 1996; Heishman et al., 2010; Hukkanen et al., 2005; Kaye et al., 2014; Le
Foll and Goldberg, 2009; Pomerleau & Pomerleau, 1992). Indeed, the recent rise in the use of
electronic cigarettes (e-cigarettes) suggests that nicotine produces strong motivational effects
(Drope et al., 2017; Yoong et al., 2019). When nicotine is consumed chronically, a withdrawal
syndrome emerges during abstinence. The withdrawal syndrome consists of physical symptoms as
well as negative affective states that include nausea, headaches, sleep disturbances, irritability,
depression, anxiety, and difficult concentrating (Hatsukami et al., 1989; Heishma et al., 2004;
Hogle et al., 2006; Hughes et al., 1992; Hughes, 2007; Pauly, 2008; Perkins et al., 2009; Shiffman
et al., 2005). The abstinence syndrome plays a major role in continued nicotine use and relapse
behavior to avoid negative symptoms that emerge during withdrawal (Baker et al., 2004; Battista
et al., 2008; Hughes, 2007, O’Dell & Torres, 2014; Piper et al., 2011). Given the importance of
nicotine reward and withdrawal to driving nicotine use, the present work compared age and sex
differences in approach behavior (Aim 1) and withdrawal severity (Aim 2) following chronic
nicotine exposure.
1.3 E-cigarette use in vulnerable populations
In 2007, e-cigarettes were introduced as a smoking cessation tool that delivers nicotine to
alleviate withdrawal symptoms during abstinence. Unfortunately, there has been an epidemic rise
in recreational e-cigarette use and an increase in dual use with traditional cigarettes (King et al.,
2015; Pepper & Brewer, 2014). There is also growing concern that e-cigarettes provide a
“gateway” for greater vulnerability to nicotine use, particularly in adolescents and females. Indeed,
adolescents who use e-cigarettes are up to four times more likely to smoke combustible cigarettes
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regularly as adults, a relationship that is stronger in females versus males (Chen et al., 2017). With
regard to sex differences, women use two-fold higher concentrations of nicotine and display
greater symptoms of nicotine dependence than men (Pang et al., 2020). Another report found that
women attribute their e-cigarette use to stress reduction and alleviation of withdrawal, whereas
men attribute their use to pleasurable effects (Pineiro et al., 2016). Women who smoke are also
more likely to have tried e-cigarettes than men (Zhu et al., 2013). This is concerning because
women are more susceptible than men to the long-term consequences of smoking, which include
reproductive problems, pulmonary disease, and cancer (Kong & Krishnan-Sarin, 2017). Women
also face greater challenges than men when attempting to quit smoking. During abstinence, women
display greater anxiety, depression, craving, and higher levels of the stress biomarker cortisol than
men (Perkins et al., 2000). Existing cessation strategies attempt to reduce withdrawal symptoms
via nicotine replacement therapy or administration of partial nicotinic acetylcholine receptor
(nAChR) agonists. Unfortunately, these interventions are less effective in women versus men
(Bottorff et al., 2012; Cepeda-Benito et al., 2004). Preclinical studies are needed to provide a
deeper understanding of underlying mechanisms that promote age and sex differences in nicotine
use, particularly with rodent models that more closely model nicotine use patterns in humans.
1.4 Pre-clinical studies that lay the foundation for this thesis
Rodent models have provided an important research tool for evaluating the factors that
promote nicotine use (FDA, 2012). Previous work has studied the behavioral and neurochemical
effects of nicotine in rodents following intravenous (IV) or oral self-administration, passive
subcutaneous (SC) or intraperitoneal (IP) injections, and surgical implantation of an osmotic pump
that delivers nicotine continuously (Matta et al., 2007; O’Dell & Khroyan, 2009). Most of the
prior work has studied withdrawal in rodents by implanting a subcutaneous pump that delivers
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nicotine and then removing the pump or administering a nicotinic acetylcholine receptor antagonist
(such as mecamylamine) to precipitate withdrawal. The pump model is limited regarding surgical
interventions, the larger size of the pump in adolescent versus adult and female versus male rats,
and continuous delivery of nicotine that does not mimic the repeated abstinence periods in human
use patterns. Given these limitations, recent efforts have focused on developing nicotine inhalation
methods to more closely model emerging nicotine use trends in clinical populations (discussed in
Miliano et al., 2020). Emerging work has established that inhalation methods induce nicotine
dependence in rats (George et al., 2010; Gilpin et al., 2014; Javadi-Paydar et al., 2019; Kallupi et
al., 2019; Montanari et al., 2020) and mice (Lefever et al., 2017; Ponzoni et al., 2015). This work
has revealed that chronic nicotine vapor exposure produces dependence in rats, as demonstrated
by the emergence of physical signs during withdrawal from 7-14 days of passive exposure to
nicotine vapor in rats (George et al., 2010; Gilpin et al., 2014; Javadi-Paydar et al., 2019; Kallupi
et al., 2019; Montanari et al., 2020). Prior work using nicotine vapor methods in rats has utilized
male adult rodents, leaving remaining questions regarding age and sex differences produced by
chronic exposure to nicotine vapor. To address this issue, the present study assessed nosepoke
responses in a port that delivered nicotine plumes in a passive vapor inhalation system. Following
nicotine vapor exposure, age and sex differences in physical signs and anxiety-like behavior were
compared following precipitated withdrawal. Group differences in weight gain and plasma levels
of cotinine (a nicotine metabolite) were also assessed on the final day of the vapor regimen.
1.5 Aims
Age and sex differences in the behavioral effects of nicotine reward and withdrawal have
not been explored. Thus, this Master’s thesis project characterized age and sex differences in the
motivational/rewarding effects of nicotine (Aim 1) and withdrawal symptoms (Aim 2) produced
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by chronic nicotine vapor exposure in female and male adolescent and adult rats. The motivational
effects of nicotine were assessed by measuring approach behavior to a port that delivers nicotine
plumes in a passive electronic nicotine vapor inhalation system. Following chronic nicotine
exposure, withdrawal-induced group differences were then assessed in physical signs, anxiety-like
behavior, and serum levels of cotinine. Withdrawal was studied following administration of
mecamylamine, a non-selective nicotinic receptor antagonist. This was done to elicit a discrete
time point of withdrawal that has been shown in our laboratory to produce sex differences (O’Dell
& Torres, 2014).
1.6 Hypotheses and rationale
For Aim 1, we hypothesized that adolescent female rats would experience a more
heightened rewarding effect of nicotine vapor, as measured as greater approach behavior to the
port that delivers nicotine in adolescent females as compared to their adult counterparts. The
rationale for our hypothesis is based on previous evidence showing that female adolescent rats
display a greater magnitude of place preference produced by nicotine as compared to adolescent
males (Torres et al., 2008; Torres et al., 2009). Self-administration studies focused on age
differences in females have also found two-fold higher levels of nicotine intake (Levin et al., 2003)
and faster acquisition of nicotine self-administration (Chen et al., 2007) in adolescent female
versus adult female rats.
For Aim 2, we hypothesized that adult rats would display greater physical signs of
withdrawal and serum cotinine levels as compared to their adolescent counterparts. The rationale
for our hypothesis is based on previous evidence from our laboratory showing that adult rats
display greater physical signs of withdrawal and serum cotinine levels produced by nicotine as
compared to adolescent rats (O’Dell, 2009; Torres et al., 2013). Additionally, we hypothesized
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that adult females would experience greater withdrawal-induced anxiety-like behavior as
compared to their adult male counterparts. The rationale for our hypothesis is based on previous
work showing that female adult rats display greater anxiety-like behavior than adult males (Torres
et al., 2013). Subsequent studies revealed that ovariectomized adult female rats displayed less
anxiety-like behavior and corticosterone levels relative to intact females (Flores et al., 2020).
Together, this work suggests that the heightened withdrawal severity in adult females is modulated
by the presence of ovarian hormones. Thus, we hypothesized that adolescent females would
display less withdrawal severity given that their ovarian hormones are not yet developed.

6

Chapter 2: Methods
2.1 Subjects
Adult female (n=6 nicotine and n=6 control), adult male (n=6 nicotine and n=6 control),
adolescent female (n=6 nicotine and n=6 control), and adolescent male (n=6 nicotine and n=6
control) rats were used. The rats were bred in house from an outbred stock of Wistar rats (Envigo,
Inc., Indianapolis, IN). On postnatal day (PND) 21, the rat pups were weaned and pair-housed with
a same-sex litter mate for the remainder of the study. The rats were housed in a humidity- and
temperature- controlled (22°C) vivarium on a reverse 12-hour light/dark cycle (lights off between
8:00 a.m. and 8:00 p.m.) with access to water and food ad libitum. All procedures were approved
by the UTEP Institutional Animal Care and Use Committee in compliance with the Guide for the
Care and Use of Animals (National Research Council, 2010).
2.2 Experimental procedures

The inset depicts our vapor exposure regimen and test procedures. Before the start of the study,
the rats were handled for at least 5 minutes each day in the vivarium for 5 days. The exposure
procedures utilized a Benchtop Passive E-Vape Inhalation system from La Jolla Alcohol Research
Inc. (La Jolla, CA). Separate pairs of rats were exposed to either nicotine (12 mg/mL) or ambient
air (controls) for 90 minutes each day for 14 consecutive days. The pairs of rats were derived from
the same group condition (i.e., a female adolescent with another female adolescent) and they
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remained with the same partner throughout the exposure procedure. Our decision to use ambient
air for the control condition was based on previous studies from our laboratory showing that
PG/VG elicits behavioral effects, such as changes in riskiness, that could impact our assessments
of approach behavior (Giner et al., 2022). Other laboratories have also used ambient air as a control
condition in nicotine vapor studies in rats (Gilpin et al., 2014).
Each day, the rats were exposed to 90-minute sessions consisting of four cycles, with 5minute inter-cycle intervals. For each cycle, nicotine e-liquid was heated to 400°F for a 3-second
puff delivery, occurring every 2 minutes and 10 times per cycle, for a total of 40 puff deliveries
per day. Each cycle duration was 18 minutes and 30 seconds. We used flavorless e-liquids
containing nicotine in its freebase form in 50/50 vegetable glycerin/propylene glycol (PG/VG)
vehicle.
The rationale for our procedures was based largely on prior studies in our laboratory and
others using nicotine vapor in rats (Flores et al., 2022; George et al., 2010; Gilpin et al., 2014;
Javadi-Paydar et al., 2019; Kallupi et al., 2019; Montanari et al., 2019; Smith et al., 2020). Our eliquid concentration of nicotine (12 mg/mL) is a moderate concentration that falls within a range
of e-liquid concentrations preferred by human e-cigarette users (Etter, 2016; Flouris et al., 2013).
Our flavorless e-liquids are purchased in bulk from a commercial vendor (Vapor Vapes Inc, Sand
City, CA) that is a popular choice among e-cigarette users. While these liquids provide a better
model of human e-cigarette use, it is acknowledged that they may vary in dose and contain
contaminants.
The 14-day exposure procedure was done in adolescent rats between PND 33-46 and adult
rats between PND 70-88. Two cage mates were exposed in the same chamber throughout the
exposure procedure. The exposure system consisted of four sealed chambers (interior dimension

8

of 14.5" L x 10.5" W x 9.0" H), each with two valve ports. One valve port was connected to a
small vacuum that controlled the airflow in the chamber at 0.6 L per minute. The vacuum outlet
was connected to a Whatman HEPA filter (Millipore Sigma, Darmstadt, Germany) and onto a
house exhaust that safely removed the nicotine from the chambers and outside the testing room.
The other valve port was connected via PVC tubing to a modified 4.9-volt TFV4 minitank (Smok
Inc, Shenzhen, China) where the nicotine was heated. The minitanks were also linked to a control
box that allowed for controlled heating of nicotine e-cigarette liquid (e-liquid). To minimize
contamination, the chambers were carefully cleaned after every exposure session, and separate
PVC tubing and minitanks were used for air controls and nicotine vapor groups.
2.3 Behavioral testing
During the exposure regimen, nosepokes in the vapor plume delivery port were recorded
on Day 1 and 14. The frequency of port contacts (nosepokes) served as an index of approach
behavior that was directed at the port where the nicotine plumes were delivered into the chamber.
Nosepoke responses were manually scored by an observer that was blind to the rats’ treatment
condition. The videos were scored two separate times manually to capture nosepoke responses for
each individual rat of the pairings. In our figures, individual data points are color matched to allow
for comparisons in each pair of rats. We did not observe any interference of nosepoking behavior
when assessing rat pairs. More animals are needed to confirm this assertion given that there were
only three pairs of rats per group in the present dataset.
At the end of the final vapor exposure session on Day 14, the rats were placed into a clear
Plexiglas® cage and moved to a dedicated test room that was well lit. Following a 10-minute
acclimation period, the rats received a subcutaneous injection of mecamylamine (3.0 mg/kg) to
precipitate nicotine withdrawal. This dose of mecamylamine elicits physical signs of withdrawal
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in nicotine-dependent female and male Wistar rats (Torres et al., 2015). Ten minutes later, the
physical signs of withdrawal were assessed for an additional 10 minutes. The observed signs
included blinks, writhes, body shakes, teeth chatters, gasps, grooming, licks, and ptosis. Each sign
was operationally defined in Table 1 with a description of the regulatory systems believed to
modulate each behavior. Multiple successive counts of any sign required a distinct pause between
episodes. Ptosis was counted once per minute.
Following our assessments of physical signs, anxiety-like behavior was assessed using
elevated plus maze (EPM) procedures. The rats were transported to another dimly lit room and
acclimated for 5 minutes. The EPM apparatus consisted of 4 arms (2 closed and 2 open) elevated
to a height of 50 cm above the ground. The apparatus was illuminated by a red light suspended
from the ceiling. At the beginning of the test, the rats were placed in the center of the EPM facing
the open arm. Time spent in the center area and the open versus closed arms was record for 5
minutes. Anxiety-like behavior was operationally defined as an increase in time spent in the closed
arms relative to controls. All behavioral measures were assessed by an observer that was unaware
of the rats’ treatment condition.
2.4 Cotinine levels assessment
Immediately after behavioral testing, the rats were sacrificed, and blood was collected.
Nicotine metabolism was assessed indirectly by comparing cotinine (a nicotine metabolite) levels
across experimental conditions. The blood was centrifuged for 15 minutes at 5000 x g at 4°C.
Serum was extracted and stored in 100 µL aliquots at -80°C. The serum cotinine levels were
analyzed using commercially available 96-well plate ELISA kits (OraSure Technologies, Inc.,
Bethlehem, PA). Standard curves were used to estimate plasma cotinine levels using a Spectra
Maxplus spectrophotometer (Molecular Devices Inc, Sunnyvale, CA).

10

2.5 Statistics
The dependent variables included, nosepoke responses, weight gain, cotinine levels, time
spent in the closed arms of the EPM, and physical signs of withdrawal. The nosepoke data and
changes in weight were expressed as a percent change from Day 1 to assess time-dependent effects
across treatment groups. Multivariate analysis of variance (ANOVA) was used with sex (female
versus male), age (adolescent versus adult), and treatment (control versus nicotine) as betweensubject factors. For the nosepoke data, time was included in the ANOVA as a within subject factor
(Day 1 versus 14). Where appropriate, significant interaction effects were further analyzed using
post-hoc comparisons (Fisher’s LSD test, p<0.05). A Bonferroni correction factor was employed
to reduce error inflation with multiple comparisons. The relationship between approach behavior
and cotinine levels was assessed using a Pearson correlation coefficient analysis. Data were
analyzed using IBM SPSS Statistics for Windows, version 27 (IBM Corp., Armonk, NY). Table
2 depicts all the statistical analyses. All significant interaction effects were depicted, and only main
effects were shown where interaction effects were not discovered.
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Chapter 3: Results
3.1 Nosepoke responses
Figure 1 displays nosepokes in control (white bars) and nicotine vapor (grey bars) groups
on Day 1 and 14 of the exposure regimen. Overall, the data show that female rats displayed an
increase in approach behavior toward a port that delivered nicotine, and this effect was larger in
adolescents. The analysis of Day 1 revealed that all rats that received nicotine vapor displayed
fewer nosepoke responses than controls (main effect of treatment: F(1,40)=13.08; *p=0.001). Also,
adolescent rats displayed more nosepoke responses than adults (main effect of age: F(1,40)=8.74;
@

p=0.005). The analysis of Day 14 revealed significant interactions between sex and treatment

(F(1,40)=12.61; p=0.001), sex and age (F(1,40)=17.80; p=0.001), and treatment and age (F(1,40)=5.61;
p=0.02). Post-hoc analyses of these interaction effects revealed that female adolescent controls
displayed more nosepoke responses than adult female controls (@p<0.05) and adolescent male
controls (†p<0.05). Female adolescent rats that were exposed to nicotine displayed more nosepoke
responses than adolescent female controls (*p<0.05) and their adult female (@p<0.05) and
adolescent male (†p<0.05) counterparts. Female adult controls displayed more nosepoke responses
than adult male controls (†p<0.05). Female adults that were exposed to nicotine displayed more
nosepoke responses than adult female controls (*p<0.05) and their adult male counterparts
(†p<0.05). Male adolescent controls displayed more nosepoke responses than adult male controls
(@p<0.05). Male adolescents that were exposed to nicotine displayed more nosepoke responses
than adolescent male controls (*p<0.05) and their adult male counterparts (@p<0.05). Male adult
rats that were exposed to nicotine displayed more nosepoke responses than adult male controls
(*p<0.05).
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Figure 2 displays nosepoke responses in control (white bars) and nicotine vapor (grey bars)
groups on Day 14 expressed as % change from Day 1. Overall, the data show that across time,
female rats display a larger increase in approach behavior, and this effect was larger in adolescents.
The analysis of adolescents revealed a significant interaction between sex, treatment, and time
(F(1,40)=8.68; p=.005). The post-hoc analyses revealed that adolescent females exposed to nicotine
vapor displayed a greater increase in nosepokes over time than female controls (*p<0.05). Also,
female adolescents that were exposed to nicotine displayed more nosepoke responses on Day 14
as compared to Day 1 (#p<0.05). On Day 14, female adolescent rats that were exposed to nicotine
also displayed more nosepoke responses than adolescent female controls (*p<0.05) and their
adolescent male counterparts (†p<0.05). Female adults that were exposed to nicotine displayed
more nosepoke responses on Day 14 as compared to Day 1 (#p<0.05). On Day 14, female adults
that were exposed to nicotine also displayed more nosepoke responses than adult female controls
(*p<0.05) and their adult male counterparts (†p<0.05). Male adults that were exposed to nicotine
displayed more nosepoke responses than adult male controls (*p<0.05).
3.2 Physical signs
Figure 3 displays physical signs of withdrawal in control (white bars) and nicotine vapor
(grey bars) groups on Day 14 of the exposure regiment. Overall, the data shows that adolescent
rats display more physical signs of withdrawal than adults. An analysis of the sum total of all
physical signs revealed a significant interaction between treatment and age (F(1,40)=9.24; p=0.004).
Post hoc analyses revealed that adolescents exposed to nicotine vapor displayed more physical
signs than adults (@p<0.05). Separate ANOVAs were also conducted for individual physical signs
that are the most objective behavioral measures of withdrawal. An analysis of teeth chatters
revealed a significant main effect of treatment (F(1,40)=13.08; p=0.001), with all rats that received
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nicotine vapor displaying an increase in teeth chatters relative to controls. A separate analysis of
blinks revealed a significant main effect of treatment (F(1,40)=103.87; p=0.001), with all rats that
were exposed to nicotine vapor displaying an increase in blinks relative to controls. There was also
a main effect of age (F(1,40)=9.64; p=0.01), with adolescents displaying less blinks than adults
regardless of sex or treatment condition. A separate analysis of grooming revealed a
significant interaction between treatment and age (F(1,40)=24.68; p=0.001). Post hoc analyses
revealed that all rats that were exposed to nicotine vapor displayed more grooming behavior as
compared to controls (* p<0.05). Also, the adolescent rats that were exposed to nicotine vapor
displayed more grooming behavior than adults (@p<0.05).
3.3 Anxiety-like behavior
Figure 4 displays anxiety-like behavior in control (white bars) and nicotine vapor (grey
bars) groups on Day 14 expressed as % time spent in the closed arms of the EPM. Overall, the data
shows that adolescent and adult rats did not display anxiety-like behavior. An analysis of % time
spent in the closed arms revealed no interaction between sex, treatment, and age (F(1,40)=0.05;
p=0.819). Also, an analysis of % time spent in the closed arms revealed no interaction between
treatment and sex (F(1,40)=0.001; p=0.98), treatment and age (F(1,40)=1.06; p=0.31), and sex and age
(F(1,40)=0.25; p=0.62). Lastly, an analysis revealed no main effect of treatment (F(1,40)=3.20;
p=0.08), sex (F(1,40)=3.07; p=0.09), or age (F(1,40)=0.14; p=0.71). We note that there was a strong
trend for treatment and sex, and this analysis would likely have reached statistical significance
with more animals in each group.
Although there were no overall group differences in anxiety-like behavior, we wanted to
examine the relationship between withdrawal severity and the magnitude of anxiety-like behavior.
Figure 5 displays our correlational analyses between approach behavior and withdrawal-induced
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changes in physical signs (top panel) and anxiety-like behavior (bottom panel) in control (open
circles with dotted lines) and nicotine vapor (closed circles with solid lines) groups on Day 14.
Overall, the results revealed that approach behavior was positively correlated with withdrawalinduced increases in anxiety-like behavior. Specifically, in adolescent females that were exposed
to nicotine vapor, nosepoke responses were positively correlated with % time spent in closed arms
(r=0.80, *p=0.05). The nosepoke responses in the nicotine-treated group were not correlated with
physical signs of withdrawal.
3.4 Body weight
Figure 6 displays changes in body weight in control (white bars) and nicotine vapor (grey
bars) groups on Day 14 expressed as % change from Day 1. Overall, the data show that adolescents
gain more weight than adults, and the magnitude of weight gain was greater in males. The analysis
of adolescent rats revealed a significant interaction between sex and time (F(1,40)=6.63; p=0.001).
Post-hoc analyses revealed that all adolescent rats gained weight across time (#p<0.05), an effect
that was larger in males (†p<0.05). The analysis of adult rats revealed a main effect of time
(F(1,40)=5.77; p=0.02), with all adult rats gaining some weight across time (#p<0.05). Lastly, there
was a larger increase in weight gain in adolescent versus adult rats regardless of their treatment
condition (@p<0.05).
3.5 Cotinine levels
Figure 7 displays cotinine levels in control (white bars) and nicotine vapor (grey bars)
groups on Day 14. Overall, the data reveal that adolescent females that were exposed to nicotine
vapor displayed the largest increase in cotinine levels at the end of the final exposure session. The
overall analysis revealed a significant interaction between sex, age, and treatment (F(1,40)=8.94;
p=0.005). All rats that were exposed to nicotine vapor displayed an increase in cotinine levels
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relative to their respective control group (*p<0.05). Adolescent females that were exposed to
nicotine vapor displayed higher cotinine levels than adult females (@p<0.05) and adolescent males
(†p<0.05).
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Chapter 4: Discussion
4.1 Summary
In summary, our major finding was that female rats displayed greater approach behavior
to a port that delivered nicotine vapor as compared to males, and this effect was larger in
adolescents. Following precipitated nicotine withdrawal, both female and male adolescent rats
displayed a larger increase in all physical signs combined relative to adults. An analysis of the
individual signs revealed that withdrawal-induced increases in teeth chatters were similar across
age and sex. Blinking behavior was higher in adults versus adolescent rats regardless of sex. There
was no significant difference in the magnitude of anxiety-like behavior across all treatment groups
during

withdrawal.

However,

a

correlational

analysis

revealed

that

in

adolescent

females, approach behavior was positively correlated with the magnitude of anxiety-like behavior,
but not physical signs of withdrawal. Over time, adolescent rats gained more weight than adults,
and this effect was larger in adolescent males regardless of their treatment condition. Not
surprisingly, female adolescents that exhibited the largest amount of nosepoke responses in the
port that delivered nicotine also displayed the highest levels of the nicotine metabolite, cotinine.
4.2 Nosepoke responses
A major finding of the present report was that across time adolescent female rats displayed
the largest increase in approach behavior toward the delivery site of the nicotine vapor plumes.
The time-dependent increase in the magnitude of nosepoke responses is believed to reflect greater
nicotine reward-seeking behavior in adolescent females. This interpretation of our nosepoke data
is consistent with previous work comparing age and sex differences in the rewarding effects of
nicotine. For example, the magnitude of place preference produced by nicotine is larger in female
adolescent rats as compared to their male counterparts (Torres et al., 2008; Torres et al., 2009).
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Another report using intravenous self-administration procedures revealed that female adolescent
rats display two-fold higher levels of nicotine intake relative to female adults (Levin et al., 2007).
Adolescent female rats also acquire nicotine self-administration more rapidly and maintain higher
levels of nicotine intake than adults (Chen et al., 2007). In a meta-analysis that included all of the
existing nicotine self-administration studies in rats, the major conclusion was that the magnitude
of nicotine intake is larger in female versus male rats, and the effect size was larger in adolescents
(Flores et al., 2019). Thus, the present study supports prior work demonstrating that the reinforcing
effects of nicotine are greater in adolescent rats, particularly female adolescents.
The present study extends prior work by showing that the motivational effects of nicotine
vapor are stronger in females during the adolescent period of development. Prior reports have
compared nicotine vapor self-administration in rodents. One report in adult male mice found that
reliable nicotine vapor self-administration required the addition of menthol or flavorants (Cooper
et al., 2021). Another report showed stable nicotine vapor self-administration in adult female and
male rats, albeit with low discrimination between the active and inactive lever (Smith et al., 2020).
Indeed, another report comparing sex differences found that the discriminative stimulus effects of
nicotine vapor were lower in females versus males (Lefever et al., 2019). A recent report also
revealed that adolescent male rats displayed larger shifts in preference behavior than adult males
using a shorter puff duration than was used in the present study (Frie et al., 2020). Another study
found that adolescent female mice escalated their consumption of a flavored nicotine solution as
compared to male adolescent male mice (Patten et al., 2021). Together with existing work, the
present findings suggest that the discriminative stimulus and reinforcing effects of nicotine are
enhanced in adolescent female rats. It is noted that adolescent female controls displayed higher
nosepoke responses for the port that delivered ambient air. In prior work with self-administration
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procedures, we have noted that adolescent rats display higher responding on an inactive lever as
compared to adults (Natividad et al., 2013). Thus, in the present study the nosepoke responses in
the air port are believed to reflect hyperactivity in young animals. Importantly, our effects appear
to be specific to nicotine given that adolescents displayed higher nosepoke responses for the port
that delivered nicotine as compared to air controls, suggesting that our effects were motivated by
the rewarding effects of nicotine.
4.3 Physical signs of withdrawal
The present study also revealed that there were no sex differences in the physical signs of
withdrawal, consistent with previous work in our laboratory using nicotine pump exposure (Correa
et al., 2019; Flores et al., 2020; Torres et al., 2013). Our findings are also consistent with another
laboratory using similar experimental conditions (Hamilton et al., 2009). The latter report also
found that male rats display greater physical signs of withdrawal than females in a dimly lit test
room, suggesting that sex differences in physical signs may emerge under certain lighting
conditions. A comparison across age groups revealed that adolescents displayed more total
physical signs of withdrawal than adults, an effect that is likely related to high levels of nosepoke
responses in adolescent rats. Indeed, prior work revealed that the magnitude of precipitated
withdrawal signs was positively correlated with the amount of nicotine that was intravenously selfadministered (O’Dell et al., 2006) or passively delivered via vapor exposure (George et al., 2010).
Our assessment of physical signs also included an analysis of individual behaviors. The
individual signs are shown in Table 1 with the definition of each behavior and the putative system
that modulates these behaviors. The analysis of individual signs revealed that there were no age or
sex differences in the withdrawal-induced increases in teeth chatters. The pattern of age and sex
differences in grooming behavior was similar to our findings with our analysis of the sum total
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physical signs. However, the withdrawal-induced increase in blinking behavior was higher in adult
versus adolescent rats, regardless of sex. These results suggest that age and sex differences in the
individual behavioral signs of withdrawal can vary from conclusions that are based on total
physical signs of withdrawal. The possibility exists that the individual signs reflect a different
manifestation of the withdrawal syndrome. In fact, a recent report utilized fiber photometry in the
interpeduncular nucleus (IPN) to provide a rapid and time-locked assessment of the behavioral
effects of nicotine withdrawal with neural activity in this region (Avelar and George, 2022). Their
goal was to compare neural activity in the IPN and collected various behaviors associated with the
expression of negative emotional states or coping behaviors, such as grooming. They observed
that the IPN GABA neuron activity ramped up before a grooming/scratching episode and
rebounded after the grooming episode. They interpreted their data to suggest that these withdrawalrelated behaviors emerge as a coping mechanism to reduce the increase in IPN GABA neurons
activity that is caused by an increase in anxiety-like behavior during withdrawal. Another report
assessed the effects of mecamylamine on neural activity in IPN GABAergic neurons with various
behavioral measures in nicotine-dependent mice (Klenowski et al., 2021). They found that somatic
symptoms including grooming and scratching reduced IPN GABAergic activity during
withdrawal. In the elevated plus maze, used to measure anxiety-like behavior, they found that IPN
GABAergic neuron activity was increased in the IPN during open- versus closed-arm exploration
during withdrawal. Taken together, the existing literature suggests that GABAergic transmission
in the IPN, which is enriched in nicotinic receptors, controls the emotional, physical, and
motivational aspects of nicotine withdrawal. Future work is needed to better understand how each
individual behavior varies across age and sex during withdrawal. Moreover, future work is needed
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to determine whether the different physical signs of withdrawal are modulated via distinct brain
mechanisms.
4.4 Anxiety-like behavior
The present study revealed that there were no age and sex differences in anxiety-like
behavior. These findings were not consistent with previous work in our laboratory showing that
adult females and adolescent males spent more time on the closed arms of the elevated plus maze
during nicotine withdrawal as compared to males (Torres et al., 2013). One possible explanation
for this discrepancy with our prior work is that the saline controls in the present study displayed
more time in the closed arms, suggesting that the present cohort of animals were more stressed
than animals in the Torres et al paper. A major goal of this report was to provide insight into the
role of nicotine dependence in motivating approach behavior in female and male rats from different
age groups. To address this issue, we conducted a correlational analysis between nosepoke
responses and the magnitude of withdrawal severity (physical signs of withdrawal and anxietylike behavior). Our analysis revealed that in female adolescent rats, the magnitude of approach
behavior following nicotine vapor exposure was closely associated with the expression of anxietylike behavior during withdrawal. Interestingly, there was no correlation between approach
behavior and physical signs of withdrawal. These findings suggest that adolescent females may be
more motivated to seek nicotine following repeated exposure to alleviate negative affective states
produced by withdrawal. Prior work in our laboratory has found that withdrawal severity is lower
in adolescent versus adult rats that received nicotine via osmotic minipumps (see O’Dell, 2009).
Thus, the possibility exists that age differences in withdrawal may vary in procedures involving
passive and continuous delivery of nicotine as compared to procedures involving volitional intake
of inhaled nicotine vapor.
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4.5 Body weight
It is recognized that group differences in body weight have the potential to influence the
amount of nicotine that is absorbed. One might expect that following exposure to the same amount
of nicotine, a large animal might display lower nicotine levels as compared to a smaller rat due to
differences in size. However, in the present study the female adolescent rats displayed higher
nosepoke responses and the highest cotinine levels relative to all other groups. The analysis of
changes in body weight revealed that adolescent rats gained more weight than adults regardless of
treatment. This pattern of results is consistent with a prior self-administration study showing that
both female and male adolescent rats gained more weight than adults regardless of their selfadministration history (Schassburger et al., 2016). Thus, group differences in body weight do not
likely explain the pattern of results in nosepoke responses that were age- and sex-dependent.
4.6 Cotinine levels
The present study found that female adolescents that displayed the largest increase in
nosepoke responses in the port that delivered nicotine displayed the highest cotinine levels. Since
cotinine is a direct metabolite of nicotine with a longer half-life, the assessments of cotinine served
as a biomarker for detecting different levels of nicotine intake across treatment groups. The
increased cotinine levels observed in rats that spent more time near the vapor input port is likely
driven by higher nicotine intake through inhalation, and in part, through oral and transdermal
absorption.
4.7 Limitations
The present study used 90-minute sessions for vapor exposure, which reflects a limited
exposure period as compared to e-cigarette use in humans, who inhale e-cigarette
vapor throughout the day (Dawkins et al., 2013). Thus, we recognize the need to examine age and
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sex differences using longer sessions across an extended period. This is important given prior work
showing that the escalation of nicotine intake is observed in rats that are given extended access to
nicotine intake with intravenous self-administration procedures (see O’Dell et al., 2007). Indeed,
ongoing efforts to establish nicotine vapor self-administration will be critical for studying age and
sex differences under voluntarily access to nicotine vapor conditions. Another consideration is that
prior work using osmotic pumps revealed that nicotine metabolism is faster in adolescent rats
(Torres et al., 2013; Trauth et al., 2000). However, the present study revealed that adolescent
females that displayed the highest amount of nosepoke responses also had the highest cotinine
levels. We believe that the higher cotinine levels are a direct result of greater nicotine exposure in
female adolescent rats. However, future work is needed to better understand age and sex
differences produced by nicotine following different routes of administration. Indeed, a prior study
found that male rats displayed similar cotinine levels following exposure to nicotine via inhalation
or intravenous administration, however, females displayed differences in nicotine metabolism
across these different routes of administration (Lallai et al., 2021). Taken together, these findings
reveal important sex differences in nicotine metabolism based on the route of exposure, an issue
that we will need to carefully consider when we make group comparisons in our nicotine vapor
self-administration studies in rats.
Another limitation of this report is that our video recordings were unable to capture facial
expressions or ultrasonic vocalizations, both of which can provide opportunities for a microstructural analysis of affective states. For example, prior work has shown that rodents display
facial responses that signal disgust or liking versus wanting processes (Khan et al., 2020). Also,
prior work has revealed that rats emit ultrasonic vocalizations in the 22-25 kHz range during
withdrawal from opiates and cocaine (Covington and Miczek, 2003). Thus, more detailed video
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recordings and/or ultrasonic vocalizations might be incorporated in future work aimed at
understanding the motivation for nosepoke responses for nicotine vapor in rats.
4.8 Conclusion
The present work lays a foundation for ongoing efforts to establish nicotine vapor selfadministration, led by the Mendez laboratory. Our plan for future studies is to utilize a two-phase
procedure whereby the rats will first receive passive delivery of nicotine vapor before the animals
are allowed to nosepoke for additional nicotine plumes. Based on the present findings, it is
expected that the rats will readily self-administer nicotine vapor given that over time they display
an increase in nosepokes in the port that delivered the nicotine plumes. It is also expected that
females will display the quickest acquisition of instrumental responding and the highest level of
self-administration behavior, particularly if the second phase of the study is initiated during
adolescence. Our predictions are supported by prior work showing that female rats display greater
approach responses to nicotine-predictive cues than males (Stringfield et al., 2019). The present
work is an important first step in our long-term goal of elucidating the mechanisms that modulate
age and sex differences in nicotine use.
In conclusion, there are clinical implications of the present work. First, our work suggests
that nicotine produces strong motivational/rewarding effects that largely motivate e-cigarette use
during adolescence. Also, it is likely that nicotine use may enhance the positive effects of other
substances commonly abused in adolescents, including alcohol (Schmid et al., 2007). Additionally,
the pleasurable effects of nicotine may facilitate risky behavior and social interaction that elicits
strong positive affective states in adolescents. This implies that an important strategy for reducing
nicotine use in adolescence should focus on avoidance strategies to reduce experimentation and
access to e-cigarettes in young persons. Regarding withdrawal, the present study revealed age
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differences in nicotine withdrawal severity. The current diagnostic criteria for nicotine dependence
are based largely on adults. Thus, these criteria may need to be reconsidered for adolescent nicotine
users. Also, the current cessation treatments that focus on alleviating withdrawal may produce
different clinical outcomes in nicotine users from different demographic age groups.
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Table 1. Individual Physical Signs of Withdrawal
Physical Signs
of Withdrawal
Blinks

Yawns

Teeth chatters

Gasps

Writhes

Body shakes

Head shakes

Ptosis

Grooming

Licks

Definition and Modulatory Systems
Rapid opening and closing of both eyes
associated with nicotine withdrawal. Elicited
by dopamine D1 agonist administration.
Opening of the mouth widely. Associated
with alcohol and opioid withdrawal. Elicited
by dopamine D3 receptor activation.
Rapid chattering of the teeth. Associated
with alcohol and opioid withdrawal. Elicited
by thyrotropic releasing hormone in the
hypothalamus.
Rapid and audible inhale and exhale.
Associated with opioid and nicotine
withdrawal. Modulated by brainstem systems
in the pons and medulla.
Contraction of abdominal muscles that move
up the body. Associated with nicotine and
opioid withdrawal. Regulated via
serotonergic and opioid systems.
Shaking of the body up to the shoulders.
Associated with alcohol and opioid
withdrawal. Elicited by the thyrotropic
releasing hormone in the hypothalamus.
Shaking of the head. Associated with alcohol
and nicotine withdrawal. Elicited by
serotonin 2A receptor activation.
Half closing of both eyelids and is usually a
symptom of malaise. Associated with opioid
and nicotine withdrawal. Elicited by
inhibition of monoamine release.
Licking/washing of the forepaws, face,
and/or body. Purported to reflect selfsoothing during nicotine withdrawal.
Associated with GABA neuron activation in
the interpeduncular nucleus.
Tongue extends and retracts on the body
and/or surfaces. Associated with liking and
motivated behavior. Elicited by dopamine
D1 and D2 receptor activation.
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Table 2. Statistical Analyses.
Figure

Panel

Test

Dependent
Variables

Independent
Variables

1

Day 1

3-way
ANOVA

Nosepokes

Age
Sex
Treatment

1

Day 14

3-way
ANOVA

Nosepokes

Age
Sex
Treatment

2

Adolescents

3-way
ANOVA

2

Adults

3-way
ANOVA

Nosepokes
% change
from Day 1
Nosepokes
% change
from Day 1

Time
Sex
Treatment
Time
Sex
Treatment

3A

Adolescents
& Adults

3-way
ANOVA

Total Physical
Signs

Age
Sex
Treatment

3B

Adolescents
& Adults

3-way
ANOVA

Teeth
Chatters

Age
Sex
Treatment

3C

Adolescents
& Adults

3-way
ANOVA

Blinks

Age
Sex
Treatment

3D

Adolescents
& Adults

3-way
ANOVA

Grooming

Age
Sex
Treatment

4

Adolescents
& Adults

3-way
ANOVA

% time spent
in closed arm

Age
Sex
Treatment

5A

Adolescents

Pearson’s
correlation

Nosepokes vs
Physical
Signs

Sex
Treatment

5B

Adults

Pearson’s
correlation

Nosepokes vs
Physical
Signs

Sex
Treatment

5C

Adolescents

Pearson’s
correlation

Nosepokes vs
% time spent
in closed arm

Sex
Treatment

5D

Adults

Pearson’s
correlation

Nosepokes vs
% time spent
in closed arm

Sex
Treatment

6

Adolescents

3-way
ANOVA

Body Weight
% change
from Day 1

Time
Sex
Treatment

6

Adults

3-way
ANOVA

Body Weight

Time
Sex

Comparison

Statistical value

p-value

Effect size

Age
Sex
Treatment
Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment
Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment

F(1,40) = 8.74
F(1,40) = 0.01
F(1,40) = 13.08
F(1,40) = 1.24
F(1,40) = 0.58
F(1,40) = 0.15
F(1,40) = 0.46
F(1,40) = 17.80
F(1,40) = 5.61
F(1,40) = 12.61
F(1,40) = 1.76

p = 0.005*
p = 0.91
p < 0.001*
p = 0.27
p = 0.45
p = 0.70
p = 0.50
p < 0.001*
p = 0.02*
p < 0.001*
p = 0.19

η2 = 0.18
η2 < 0.001
η2 = 0.25
η2 = 0.03
η2 = 0.01
η2 = 0.004
η2 = 0.01
η2 = 0.31
η2 = 0.12
η2 = 0.24
η2 = 0.04

Time x Sex x Treatment

F(1,40) = 8.68

p = 0.005*

η2 = 0.18

Time x Sex x Treatment

F(1,20) = 17.83

p < 0.001*

η2 = 0.31

Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment
Age
Sex
Treatment
Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment
Age
Sex
Treatment
Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment
Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment
Age
Sex
Treatment
Age x Sex
Age x Treatment
Sex x Treatment
Age x Sex x Treatment
Control Females
Control Males
Nicotine Females
Nicotine Males
Control Females
Control Males
Nicotine Females
Nicotine Males
Control Females
Control Males
Nicotine Females
Nicotine Males
Control Females
Control Males
Nicotine Females
Nicotine Males
Time x Sex
Time x Treatment
Sex x Treatment
Time x Sex x Treatment
Time
Sex

F(1,40) = 0.05
F(1,40) = 9.24
F(1,40) = 1.11
F(1,40) = 0.05
F(1,40) = 0.58
F(1,40) = 1.30
F(1,40) = 13.08
F(1,40) = 1.30
F(1,40) = 0.91
F(1,40) = 1.78
F(1,40) = 0.91
F(1,40) = 9.64
F(1,40) = 0.11
F(1,40) = 103.87
F(1,40) = 0.30
F(1,40) = 0.01
F(1,40) = 0.83
F(1,40) = 0.16
F(1,40) = 0.22
F(1,40) = 24.68
F(1,40) = 1.22
F(1,40) = 0.40
F(1,40) = 0.14
F(1,40) = 3.07
F(1,40) = 3.20
F(1,40) = 0.25
F(1,40) = 1.06
F(1,40) = 0.001
F(1,40) = 0.05
r = -0.66
r = 0.41
r = 0.25
r = -0.13
r = 0.07
r = -0.15
r = -0.11
r = -0.13
r = 0.20
r = 0.17
r = 0.80
r = -0.58
r = -0.27
r = -0.36
r = 0.59
r = 0.08
F(1,40) = 6.63
F(1,40) = 0.08
F(1,40) = 0.01
F(1,40) = 0.01
F(1,40) = 5.77
F(1,40) = 0.81

p = 0.82
p = 0.004*
p = 0.30
p = 0.82
p = 0.45
p = 0.26
p < 0.001*
p = 0.26
p = 0.35
p = 0.19
p = 0.35
p = 0.003*
p = 0.74
p < 0.001*
p = 0.59
p = 0.91
p = 0.37
p = 0.69
p = 0.64
p < 0.001*
p = 0.28
p = 0.53
p = 0.71
p = 0.09
p = 0.08
p = 0.62
p = 0.31
p = 0.98
p = 0.82
p = 0.16
p = 0.41
p = 0.64
p = 0.81
p = 0.90
p = 0.78
p = 0.84
p = 0.81
p = 0.71
p = 0.75
p = 0.05*
p = 0.22
p = 0.61
p = 0.48
p = 0.21
p = 0.88
p = 0.01*
p = 0.78
p = 0.92
p = 0.92
p = 0.02*
p = 0.38

η2 = 0.001
η2 = 0.19
η2 = 0.03
η2 = 0.001
η2 = 0.01
η2 = 0.03
η2 = 0.25
η2 = 0.03
η2 = 0.02
η2 = 0.04
η2 = 0.02
η2 = 0.19
η2 = 0.003
η2 = 0.72
η2 = 0.01
η2 < 0.001
η2 = 0.02
η2 = 0.004
η2 = 0.01
η2 = 0.38
η2 = 0.03
η2 = 0.01
η2 = 0.003
η2 = 0.07
η2 = 0.07
η2 = 0.01
η2 = 0.03
η2 < 0.001
η2 = 0.001
--------------------------------2
η = 0.14
2
η = 0.002
η2 < 0.001
η2 < 0.001
η2 = 0.13
η2 = 0.02

40

% change
from Day 1

7

Adolescents
& Adults

3-way
ANOVA

Cotinine
levels

Treatment

Age
Sex
Treatment

Treatment
Time x Sex
Time x Treatment
Sex x Treatment
Time x Sex x Treatment

F(1,40) = 0.36
F(1,40) = 0.80
F(1,40) = 0.37
F(1,40) = 0.21
F(1,40) = 0.21

p = 0.55
p = 0.38
p = 0.55
p = 0.65
p = 0.65

Age x Sex x Treatment

F(1,40) = 8.94

p = 0.005*
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η2 = 0.01
η2 = 0.02
η2 = 0.01
η2 = 0.01
η2 = 0.01
η2 = 0.18

Figure 1. The data reflect mean (± SEM) nosepoke responses in a port that delivered nicotine
vapor or ambient air (control) in female and male adolescent and adult rats on Day 1 and Day 14
of the exposure regimen. Individual data points are color matched to allow for comparisons in each
pair of rats. The asterisks (*) denote a significant difference from controls, the daggers (†) denote
a difference from males, and the at sign (@) denotes a difference from adults (p<0.05).
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Figure 2. The data reflect mean (± SEM) nosepoke responses on Day 14 expressed as % change
from Day 1 in female and male adolescent and adult rats. Individual data points are color matched
to allow for comparisons in each pair of rats. The asterisks (*) denote a significant difference from
controls, the daggers (†) denote a difference from males, and the number signs (#) denote a
difference from Day 1 of the exposure regimen (p<0.05).
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Figure 3. The data reflect mean (± SEM) total physical signs (A), teeth chatters (B), blinks (C),
and grooming (D) in female and male adolescent and adult rats on Day 14 of the exposure
regimen following precipitated withdrawal. The asterisks (*) denote a significant difference from
controls and the at sign (@) denotes a difference from adults (p<0.05).
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Figure 4. The data reflect mean (± SEM) anxiety-like behavior on Day 14 expressed as % time
spent in the closed arm of the EPM in female and male adolescent and adult rats.
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Figure 5. The data reflect a correlational analysis between nosepoke responses and withdrawalinduced increases in physical signs and anxiety-like behavior, which is noted as % time spent in
the closed arm of the EPM on Day 14. The asterisk (*) denotes a significant correlation between
nosepoke responses and % time spent in the closed arm of the EPM (p<0.05).
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Figure 6. The data reflect mean (± SEM) changes in body weight on Day 14 expressed as %
change from Day 1 in female and male adolescent and adult rats. Individual data points are color
matched to allow for comparisons in each pair of rats. The daggers (†) denote a significant
difference from males, the at sign (@) denotes a difference from adults, and the number signs (#)
denote a difference from Day 1 (p<0.05).
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Figure 7. The data reflects mean (± SEM) serum cotinine levels in female and male adolescent
and adult rats on Day 14 of the exposure regimen. Individual data points are color matched to
allow for comparisons in each pair of rats. The asterisks (*) denote a significant difference from
controls, the dagger (†) denotes a difference from males, and the at sign (@) denotes a difference
from adults (p<0.05).

48

Vita
Veronika Evangelina Espinoza was born and raised in Escondido, California. In 2018, she
completed her Bachelor’s degree in Biochemistry and received two minors in Psychology and
Mathematics at the California State University of San Marcos. Veronika became interested in
Behavioral Neuroscience research as an undergraduate and began conducting research in the
laboratory of Dr. Keith A. Trujillo. Her research focused on the locomotor effects of amphetaminelike stimulants in adolescent and adult rodents. Afterwards, she worked as a post-baccalaureate
student at The Scripps Research Institute in La Jolla, California in the Neuroscience laboratory of
Dr. Olivier George. There, her research focused on early life exposure mimicking clinical use of
oxycodone in adolescents and how that altered drug-seeking and escalation behavior during
adulthood. In August of 2019, Veronika joined the Doctoral Program in Psychology at The
University of Texas at El Paso under the mentorship of Dr. Laura E. O’Dell. Her research interests
include understanding the mechanisms that promote age and sex differences in the behavioral
effects of nicotine withdrawal. Veronika graduated with her Master’s degree in Experimental
Psychology in May of 2022. She had 10 oral and 19 poster abstracts accepted at numerous
scientific conferences. She received the National Award of Excellence in Research by a graduate
student from the National Hispanic Science Network and a fellowship award from the Enhanced
Interdisciplinary Research Training Institute (eIRTI) at the University of Southern California.
Veronika has published 1 first-author article and co-authored 1 publication in peer-reviewed
journals such as Drug and Alcohol Dependence and the Journal of the Experimental Analysis of
Behavior.
Contact information: vespinoza12@miners.utep.edu
This Master’s Thesis was typed by Veronika Evangelina Espinoza.
49

